Compounds > cb 10375
Page last updated: 2024-08-26

cb 10375 and Neoplasms

cb 10375 has been researched along with Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coley, HM1
Abel, G; Ashley, SE; Cairnduff, F; Calvert, AH; Evans, BD; Graham, MA; Gumbrell, LA; Judson, IR; Rutty, CJ; Wilman, DE1

Reviews

1 review(s) available for cb 10375 and Neoplasms

ArticleYear
N-(Hydroxymethyl) melamines.
    General pharmacology, 1997, Volume: 28, Issue:2

    Topics: Altretamine; Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Neoplasms; Triazines

1997

Trials

1 trial(s) available for cb 10375 and Neoplasms

ArticleYear
Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine).
    Cancer research, 1989, Oct-01, Volume: 49, Issue:19

    Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Neoplasms; Ovarian Neoplasms; Triazines; Vomiting

1989